CHI3L1 emerges as a powerful biomarker for liver disease diagnosis and management
The identification of Chitinase-3-like protein 1 (CHI3L1) as a crucial biomarker in liver disease is revolutionizing how clinicians…
Combination treatment approach shows promise for hard-to-treat triple-negative breast cancer
A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that…